Cargando…

The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer

Circular RNAs (circRNAs) are a type of endogenous non-coding RNA and a critical epigenetic regulation way that have a closed-loop structure and are highly stable, conserved, and tissue-specific, and they play an important role in the development of many diseases, including tumors, neurological disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Changning, Wei, Jianxia, Li, Mengna, Chen, Shipeng, Zheng, Lemei, Zhan, Yuting, Duan, Yumei, Deng, Hongyu, Xiong, Wei, Li, Guiyuan, Li, Hui, Zhou, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562909/ https://www.ncbi.nlm.nih.gov/pubmed/36231036 http://dx.doi.org/10.3390/cells11193074

Ejemplares similares

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Understanding the roles and regulation patterns of circRNA on its host gene in tumorigenesis and tumor progression
por: Wei, Jianxia, et al.
Publicado: (2023)

NOP2/Sun RNA methyltransferase 2 is a potential pan-cancer prognostic biomarker and is related to immunity
por: Zheng, Lemei, et al.
Publicado: (2023)

CircSMARCA5: A key circular RNA in various human diseases
por: Zhu, Yi, et al.
Publicado: (2022)

BRD7 inhibits enhancer activity and expression of BIRC2 to suppress tumor growth and metastasis in nasopharyngeal carcinoma
por: Li, Mengna, et al.
Publicado: (2023)

circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer
por: Cai, Juan, et al.
Publicado: (2019)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Response to: Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Cai, Juan, et al.
Publicado: (2019)

Understanding the Dual Roles of CircHIPK3 in Tumorigenesis and Tumor Progression
por: Wei, Zeyu, et al.
Publicado: (2022)

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
por: Li, MengNa, et al.
Publicado: (2023)

Serum Extracellular Vesicle-Derived circHIPK3 and circSMARCA5 Are Two Novel Diagnostic Biomarkers for Glioblastoma Multiforme
por: Stella, Michele, et al.
Publicado: (2021)

Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis
por: Chao, Fan, et al.
Publicado: (2021)

CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
por: Barbagallo, Davide, et al.
Publicado: (2019)

circSMARCA5 Promoted Osteosarcoma Cell Proliferation, Adhesion, Migration, and Invasion through a Competing Endogenous RNA Network
por: Zhang, Hepeng, et al.
Publicado: (2020)

The GAUGAA Motif Is Responsible for the Binding between circSMARCA5 and SRSF1 and Related Downstream Effects on Glioblastoma Multiforme Cell Migration and Angiogenic Potential
por: Barbagallo, Davide, et al.
Publicado: (2021)

CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB
por: Barbagallo, Davide, et al.
Publicado: (2018)

A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the miR-181b-5p/miR-17-3p-TIMP3 axis
por: Xie, Xin, et al.
Publicado: (2021)

circSMARCA5 Is an Upstream Regulator of the Expression of miR-126-3p, miR-515-5p, and Their mRNA Targets, Insulin-like Growth Factor Binding Protein 2 (IGFBP2) and NRAS Proto-Oncogene, GTPase (NRAS) in Glioblastoma
por: Merulla, Aurora Eliana, et al.
Publicado: (2022)

Expression status of circ-SMARCA5, circ-NOL10, circ-LDLRAD3, and circ-RHOT1 in patients with colorectal cancer
por: Hussein, Neveen A., et al.
Publicado: (2023)

Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA
por: Wu, Pan, et al.
Publicado: (2020)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Emerging roles of circRNA in formation and progression of cancer
por: Yin, Yuting, et al.
Publicado: (2019)

BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition
por: Niu, Weihong, et al.
Publicado: (2020)

Circ SMARCA5 Inhibited Tumor Metastasis by Interacting with SND1 and Downregulating the YWHAB Gene in Cervical Cancer
por: Zhang, Xia, et al.
Publicado: (2021)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Research Progress of circRNAs in Head and Neck Cancers
por: Li, Panchun, et al.
Publicado: (2021)

TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2
por: Zhou, Cixiang, et al.
Publicado: (2022)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

The genetic polymorphisms of ZC3HC1 and SMARCA4 are associated with hypertension risk
por: Ma, Huijun, et al.
Publicado: (2019)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Label-free quantitative proteomics identifies Smarca4 is involved in vascular calcification
por: Wang, Chan, et al.
Publicado: (2019)

Bioinformatics Analysis: The Regulatory Network of hsa_circ_0007843 and hsa_circ_0007331 in Colon Cancer
por: Han, Zeping, et al.
Publicado: (2021)

Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia
por: Sengupta, Sarojini, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4docnv6e0cl79p8n4im9pnv22n